Gene · 3488
Papers3,939
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,939
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acute Myeloid Leukemia Causes Serious and Partially Irreversible Changes in Secretomes of Bone Marrow Multipotent Mesenchymal Stromal Cells. | Int J Mol Sci | 2023 | 37240298 | PubTator, text mining | PubMed |
| Rapid Generation of Pulmonary Organoids from Induced Pluripotent Stem Cells by Co-Culturing Endodermal and Mesodermal Progenitors for Pulmonary Disease Modelling. | Biomedicines | 2023 | 37239147 | PubTator, text mining | PubMed |
| Impacts of Mir146a Genotypes on Bladder Cancer Risk in Taiwan. | Biomedicines | 2023 | 37239070 | PubTator, text mining | PubMed |
| Genetic Alterations of Transcription Factors and Signaling Molecules Involved in the Development of Congenital Heart Defects-A Narrative Review. | Children (Basel) | 2023 | 37238360 | PubTator, text mining | PubMed |
| The Migration and the Fate of Dental Pulp Stem Cells. | Biology (Basel) | 2023 | 37237554 | PubTator, text mining | PubMed |
| Senescence induces fundamental changes in the secretome of mesenchymal stromal cells (MSCs): implications for the therapeutic use of MSCs and their derivates. | Front Bioeng Biotechnol | 2023 | 37229499 | PubTator, text mining | PubMed |
| An integrative review of nonobvious puzzles of cellular and molecular cardiooncology. | Cell Mol Biol Lett | 2023 | 37221467 | PubTator, text mining | PubMed |
| Critical Considerations for Investigating MicroRNAs during Tumorigenesis: A Case Study in Conceptual and Contextual Nuances of miR-211-5p in Melanoma. | Epigenomes | 2023 | 37218870 | PubTator, text mining | PubMed |
| Salivary gland cancer organoids are valid for preclinical genotype-oriented medical precision trials. | iScience | 2023 | 37207275 | PubTator, text mining | PubMed |
| Single-Cell Profiling Reveals Sustained Immune Infiltration, Surveillance, and Tumor Heterogeneity in Infiltrative Basal Cell Carcinoma. | J Invest Dermatol | 2023 | 37201777 | PubTator, text mining | PubMed |
| Pan-cancer analysis of oncogenic role of insulin-like growth factor-binding proteins and validation in ovarian cancer. | Cancer Med | 2023 | 37199034 | PubTator, text mining | PubMed |
| Global Single-Cell Sequencing Landscape of Adipose Tissue of Different Anatomical Site Origin in Humans. | Stem Cells Int | 2023 | 37197688 | PubTator, text mining | PubMed |
| Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma: Hypoxia in PDAC. | Transl Oncol | 2023 | 37182509 | PubTator, text mining | PubMed |
| Single-Cell Profiling Uncovers the Roles of Endometrial Fibrosis and Microenvironmental Changes in Adenomyosis. | J Inflamm Res | 2023 | 37179754 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals Atlas of Yak Testis Cells. | Int J Mol Sci | 2023 | 37175687 | PubTator, text mining | PubMed |
| Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | 37169756 | PubTator, text mining | PubMed |
| Omega-3 fatty acids and individual variability in plasma triglyceride response: A mini-review. | Redox Biol | 2023 | 37150150 | PubTator, text mining | PubMed |
| lncRNA DIRC3 regulates invasiveness and insulin-like growth factor signaling in thyroid cancer cells. | Endocr Relat Cancer | 2023 | 37130273 | PubTator, text mining | PubMed |
| Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis. | Chin Med J (Engl) | 2023 | 37130223 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma. | Front Oncol | 2023 | 37124494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3488/papers?page=17